BioPorto is trading at 0.15 as of the 19th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.15. BioPorto has about a 29 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of November 2025 and ending today, the 19th of February 2026. Click here to learn more.
BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. The company has 334.68 M outstanding shares. More on BioPorto AS
BioPorto AS [THOXF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Small-Cap' category with a current market capitalization of 121.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPorto's market, we take the total number of its shares issued and multiply it by BioPorto's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioPorto AS classifies itself under Healthcare sector and is part of Diagnostics & Research industry. The entity has 334.68 M outstanding shares.
BioPorto AS has accumulated about 86.72 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BioPorto Probability Of BankruptcyOwnership AllocationBioPorto holds a total of 334.68 Million outstanding shares. BioPorto AS shows 19.84 percent of its outstanding shares held by insiders and 8.6 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioPorto Ownership Details
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. BioPorto AS had not issued any dividends in recent years. BioPorto AS, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company was founded in 2000 and is headquartered in Hellerup, Denmark. Bioporto operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 29 people.The quote for BioPorto AS is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about BioPorto AS contact the company at 45 45 29 00 00 or learn more at https://bioporto.com.
BioPorto AS Investment Alerts
BioPorto AS generated a negative expected return over the last 90 days
BioPorto AS has some characteristics of a very speculative penny stock
The company reported the revenue of 24.25 M. Net Loss for the year was (57.11 M) with profit before overhead, payroll, taxes, and interest of 15.04 M.
BioPorto AS has accumulated about 86.72 M in cash with (64.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 20.0% of the company outstanding shares are owned by corporate insiders
BioPorto Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 121.23 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioPorto's market, we take the total number of its shares issued and multiply it by BioPorto's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
BioPorto Profitablity
The company has Profit Margin (PM) of (2.5) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.82.
Technical Drivers
As of the 19th of February, BioPorto shows the Risk Adjusted Performance of (0.09), standard deviation of 5.94, and Mean Deviation of 1.44. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of BioPorto, as well as the relationship between them. Please confirm BioPorto ASmarket risk adjusted performance and total risk alpha to decide if BioPorto AS is priced correctly, providing market reflects its regular price of 0.15 per share. As BioPorto AS appears to be a penny stock we also recommend to validate its information ratio numbers.
The output start index for this execution was zero with a total number of output elements of sixty-one. BioPorto AS Tanh Of Price Series is a hyperbolic price transformation function.
BioPorto Predictive Daily Indicators
BioPorto intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioPorto pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BioPorto's time-series forecasting models are one of many BioPorto's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioPorto's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in BioPorto without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Equity Analysis Now
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Other Information on Investing in BioPorto Pink Sheet
BioPorto financial ratios help investors to determine whether BioPorto Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioPorto with respect to the benefits of owning BioPorto security.